Up-to-date announcements, stories and opinion pieces from The AAS and researchers that we fund
Top This Week
Friday, October 30, 2020
Genetic diversity in Cameroon: an invisible obstacle in human genetic studies of malaria
Tomorrow belongs to the people who prepare for it today
Why Africa needs to address deafness
Exploring the adaptive capacity of fisheries in Africa
Trust and accountability in managing public funds
Strong trust and accountability should
Africa’s scientists have had to pick testing over genome sequencing for a coronavirus vaccine
(Courtesy: Quartz Africa)
Pools of genome sequences of SARS-CoV-2 from all over the world are currently being scrutinized by scientists for insight into the Covid-19 disease. If a vaccine is eventually discovered—based on the sequences pooled so far—Africa may end up with the ‘Rotaviruses Vaccine Problem’.
Africa’s scientists learn from past epidemics to fight Covid-19
(Courtesy Financial Times)
Keep abreast of significant corporate, financial and political developments around the world. Stay informed and spot emerging risks and opportunities with independent global reporting, expert commentary and analysis you can trust.
Taiwan, vaccines, Africa preparedness The EvidenceCoronavirus: The Evidence
(Courtesy: BBC UK)
The Evidence looks at what we know about the virus and the immune system, why does it cause mild or even no symptoms in some people but makes others very ill?
Academic communities respond to society’s needs
(Courtesy: University World News)
North African student unions and academic communities have launched several civic engagement and social responsibility initiatives, ranging from fundraising and awareness campaigns to consultancy guidance and medical initiatives, in an effort to deal with the impact of the coronavirus pandemic.
Few clinical trials are done in Africa: COVID-19 shows why this urgently needs to change
(Courtesy: The Conversation)
The World Health Organisation (WHO), in its quest to find efficacious therapies to treat COVID-19, plans to conduct a multi-arm, multi-country clinical trial. The trials have yet to begin, but ten countries have already signed up. Only one of them, South Africa, is on the African continent.
Kemri plan to produce cheap drug for cancer
The initiative by the Kenya Medical Research Institute (Kemri), if successful, could dramatically reduce the cost of some crucial cancer medicines by up to 70%.